Anzeige
Mehr »
Mittwoch, 13.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40UHG | ISIN: US7389201077 | Ticker-Symbol:
NASDAQ
13.08.25 | 21:28
0,395 US-Dollar
+9,42 % +0,034
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ASPIRE BIOPHARMA HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
ASPIRE BIOPHARMA HOLDINGS INC 5-Tage-Chart
ACCESS Newswire
180 Leser
Artikel bewerten:
(1)

Aspire Biopharma Holdings, Inc.: Aspire Biopharma Successfully Launches BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

  • BUZZ BOMB is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential

  • 30,000 BUZZ BOMB sample packs of four 50mg stick packs in each flavor distributed to convention attendees

  • Well-known fitness instructors, fitness celebrities, athletes, and influencers along with thousands of fitness enthusiasts and consumers sampled BUZZ BOMB's four bold flavors

  • As part of its launch, Aspire plans on partnering with well-known athletes and influencers across fitness training and endurance sports to accelerate consumer awareness and uptake

  • BUZZ BOMB is available for purchase at buzzbomb.buzz, the Company's new E-commerce website

ESTERO, FL / ACCESS Newswire / August 13, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced the successful launch and distribution of over 30,000 BUZZ BOMB sample four-packs, its newsublingual pre-workout supplement, at FitCon and FitExpo, held August 1-3, in Salt Lake City and Anaheim, with an estimated combined attendance in excess of 70,000 people.

BUZZ BOMB, featuring 50mg of caffeine and offered in four flavors (Tropical Fruit, Mixed Berry, Peach Mango, and Coffee Mocha), provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed. Unlike most pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMB is sprinkled under the tongue right before or during a workout for immediate effect via direct delivery to the bloodstream.

BUZZ BOMB FitExpo Launch

Click here for BUZZ BOMB FitExpo Convention August 2-3, 2025 Video

BUZZ BOMB Testimonial from Leading Figures in the Fitness World

Bobby Maximus is a UFC fighter, Ju Jitsu Masters World Champion and fitness trainer. He has broken multiple power-endurance world records and is recognized as a leading figure in the fitness world. He starred in the recent feature film "Kill Shot" and is a best-selling Men's Health author and a regular contributor to "Men's Health" magazine (https://www.menshealth.com/author/214988/bobby-maximus/).

"In just about a minute, it feels like I drank a pre-workout 20 minutes ago."

"The taste… phenomenal! I really like that."

"I work out 2-3 times a day. One of the most inconvenient things is trying to time your pre workout drink 30 minutes before your workout. "

When I have a short window, I don't want to wait 30 minutes until it kicks in. The ability to just 'dump and go' with Buzz Bomb, is powerful. It's the convenience factor!

"I love the idea behind it! It helps me keep my caffeine intake down. Especially when you train 2 to 3 times a day."

"You cannot find another pre work with 50 mgs of caffeine… and it works! I love it!"

Brandon "MidWest Kong" Copeland (pictured above, third to the right) embodies the strength of a champion and the heart of a hero. A Brazilian Jiu-jitsu Black Belt, Copeland dominated the Mixed Martial Arts scene from 2005 to 2014, showcasing tenacity and skill. Initiating the "I Stopped The Bully" campaign in 2011, he became a beacon against bullying, inspiring youth across schools and detention centers. Copeland excelled in the fitness industry, breaking records like bench pressing 225 pounds 81 consecutive times. A published children's book author, he spreads messages of hope and community.

"I took the product! Let me say thank God! No heart flutter, no itchy sensation, no crash! I don't need the hard stuff anymore…feels absolutely great! I had a great workout as well!"

Commenting on the BUZZ BOMB launch, Kraig Higginson, Interim Chief Executive Officer of Aspire, said, "The launch and consumer response to BUZZ BOMB at two of the major fitness conventions, from booth activity, product sampling, feedback, interest from fitness experts and influencers, and potential licensing partners, exceeded all of our high expectations."

Higginson added, "With BUZZ BOMB, we're raising the bar for ease of use, performance and value in the multi-billion-dollar caffeine category. We focused on creating a formula that is fast-absorbing and built for athletes, fitness enthusiasts and consumers who demand clean, effective fuel without unnecessary fillers or compromise. With online sales commencing August 1, we are now focused on increasing our marketing, expanding our third-party manufacturing capabilities, and preparing for further discussions with potential licensing partners in the nutritional and supplement space that can help us drive increased consumer awareness and accelerate our revenue potential for BUZZ BOMB."

Consumers can purchase BUZZ BOMB online at buzzbomb.buzz

BUZZ BOMB Pre-workout Benefits:

  • Speed - works nearly immediately (less than 2 minutes) vs. 20-30 minutes

  • Convenience - easy to use single-use packets vs. mixing and measuring for beverages

  • Energy management - use as needed to precisely manage caffeine intake (50mg increments)

  • Single Safe Active Ingredient - well-known benefits and use of caffeine

  • A clean manageable Energy Boost

  • Low manufacturing & packaging costs - competitive pricing with high margin potential

Aspire's BUZZ BOMB - Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout market.

About Aspire Biopharma, Inc.

Headquartered in Estero, Fl., Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit www.aspirebiolabs.com.

Safe Harbor Statement

Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Aspire Biopharma Holdings, Inc.

Contact

PCG Advisory
Kevin McGrath
+1-646-418-7002
kevin@pcgadvisory.com

SOURCE: Aspire Biopharma Holdings, Inc.



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/aspire-biopharma-successfully-launches-buzz-bombtm-pre-workout-supple-1060246

© 2025 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.